Join to View Full Profile
6651 Main StHouston, TX 77030
Phone+1 832-822-4242
Dr. Mims is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2003 - 2004- Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2001 - 2003
- Baylor College of MedicineResidency, Internal Medicine, 1999 - 2002
- Baylor College of MedicineInternship, Internal Medicine, 1998 - 1999
- Baylor College of MedicineClass of 1998
Certifications & Licensure
TX State Medical License 2001 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Publications & Presentations
PubMed
- Ancestry-associated social and genomic hallmarks linked with inferior outcome in elderly acute myeloid leukemia.Lacey S Williams, Alexis Williams, Olivia Wilkins, Sarah Mudra, Paul Sackstein
BMC Cancer. 2025-10-27 - Clinical Outcomes and Patterns of Care Among Patients With Newly Diagnosed Classical Hodgkin Lymphoma in a Safety-Net Health System.Trung Minh Nguyen, Jason Lu, Danielle Guffey, Rockbum Kim, Abiodun Oluyomi
Clinical Lymphoma, Myeloma & Leukemia. 2025-08-14 - Real-world effectiveness of darolutamide in metastatic castration-resistant prostate cancer.Alyssa Liang, Shuchi Gulati, Quillan Huang, Heidi Dowst, Aedric Lim
Endocrine-Related Cancer. 2025-06-01
Abstracts/Posters
- Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk StratificationMartha P. Mims, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemi...Martha P. Mims, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during InductionMartha P. Mims, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Cancer Treatment Study in Harris County Aiming to Bring More Patients Access to Life-Saving CareFebruary 21st, 2025- Harris Health System Receives Elite Commission on Cancer AccreditationFebruary 10th, 2022
- Baylor Receives More Than $20 Million in CPRIT FundingAugust 19th, 2021
Grant Support
- OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net SystemBAYLOR COLLEGE OF MEDICINE2021–2027
- Clinical Trials Support UnitNational Cancer Institute2007–2011
- Dmt1:Tissue Specific Expression &Alternative SplicingNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
- Dynamics Of APOE Binding To Lipoproteins And ReceptorsNational Heart, Lung, And Blood Institute1993–1997
- Studies Of Cholesteryl Ester Rich LipoproteinsNational Heart, Lung, And Blood Institute1985–1987
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
